DERMAGO GmbH is a service company covering the following topics:
– solving special, analytical challenges for a fee
– the services include: consulting activities, scientific assessments, preparation of expert opinions, qualitative and quantitative studies especially in dermatological pharmaceuticals. development of analytical methods & procedures as well as working techniques in the pharmaceutical field and work on the registration of medicinal products
– the acquisition as well as the administration, utilization and sale of participations in companies and other assets, in each case in one’s own name and for one’s own account, not as a service for third parties, as well as
– the provision of consulting services to companies, in particular in the fields of strategy and business development, organization, information technology and marketing, in each case excluding activities requiring a license under the German Banking Act, the German Investment Code or the German Legal Services Act.
thereof
Approved: 3
In the approval process: 2
In development: 1
Brands: 3
Taglines: 1
Indications approved 3
Indications under development 2
Project name: Promotion of employees through subject-specific further training
Objectives and (expected) results: The aim of further training is to improve the skills of employees through subject-specific further training in their areas of work. The further training measures are intended to promote the development of competence.
Funded by the European Union and the State of Brandenburg
DERMAGO GmbH is the owner of the subsidiaries Aresus Pharma GmbH, DEGODE Pharma GmbH and Skin Care Pharma GmbH. We are active in the pharmaceutical field (development and distribution of generics). In order to expand our team, we are always looking for reinforcement. Take a look at the current job offers.
Generics, as well as so-called biosimilars, are subject to the same quality and efficacy requirements as the preparations of the first manufacturers. During the approval process in Germany, the quality and efficacy of the drug are thoroughly investigated and tested.
Generics are indispensable. Approx. 77 out of 100 patients treated with drugs receive a generic drug.
Generics are used frequently in the therapy of widespread diseases such as hypertension, heart failure, diabetes and skin diseases.
